Document Detail

Advances in The Therapy of Atrial Fibrillation: Incrementally Progressive But Not Without Missteps.
MedLine Citation:
PMID:  24821655     Owner:  NLM     Status:  Publisher    
Advances in the therapy of atrial fibrillation (AF) have not come easily or quickly, despite the recognized need for significantly better antiarrhythmic agents for AF termination and prevention as well as for more user-friendly anticoagulants for the prevention of emboli in patients with AF. Rather, the road has been only slowly progressive and bumpy. This manuscript will introduce the recent issues with dronedarone, the complex development story for vernakalant, and the appearance of the new oral anticoagulants. Each of these three considerations will then be explored in more depth by the invited experts for this "mini-thematic issue" in Current Cardiology Reviews.
James A Reiffel
Related Documents :
7089845 - Qualitative measurement of cerebral infarction using ultraviolet fluorescence.
7305695 - Medial frontal cortex infarction and the alien hand sign.
6839225 - Anticoagulation in cerebral embolism.
17903945 - The window of opportunity for treatment of focal cerebral ischemic damage with noninvas...
3229115 - Prognostic significance of late potentials after myocardial infarction.
10735705 - Surgical closure of apical ventricular septal defects through a right ventricular apica...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-5-13
Journal Detail:
Title:  Current cardiology reviews     Volume:  -     ISSN:  1875-6557     ISO Abbreviation:  Curr Cardiol Rev     Publication Date:  2014 May 
Date Detail:
Created Date:  2014-5-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101261935     Medline TA:  Curr Cardiol Rev     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The Vernakalant Story: How Did it Come to Approval in Europe and What is the Delay in the U.S.A?
Next Document:  The Role of Dronedarone in the Treatment of Atrial Fibrillation/Flutter in the Aftermath of PALLAS.